Equities

Netscientific PLC

NSCI:LSE

Netscientific PLC

Health CareMedical Equipment and Services
  • Price (GBX)69.00
  • Today's Change3.50 / 5.34%
  • Shares traded48.46k
  • 1 Year change0.73%
  • Beta2.1776
Data delayed at least 20 minutes, as of May 17 2024 14:37 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Netscientific PLC's revenues fell -9.30% from 1.11m to 1.00m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 2.39m to a larger loss of 3.09m.
Gross margin82.28%
Net profit margin-262.91%
Operating margin-263.63%
Return on assets-17.64%
Return on equity-17.69%
Return on investment-20.02%
More ▼

Cash flow in GBPView more

In 2022, cash reserves at Netscientific PLC fell by 1.86m. Cash Flow from Financing totalled 1.74m or 173.31% of revenues. In addition the company used 3.11m for operations while cash used for investing totalled 530.00k.
Cash flow per share-0.1365
Price/Cash flow per share--
Book value per share0.7888
Tangible book value per share0.643
More ▼

Balance sheet in GBPView more

Netscientific PLC has a Debt to Total Capital ratio of 9.81%, a higher figure than the previous year's 2.99%.
Current ratio0.3055
Quick ratio0.2836
Total debt/total equity0.1062
Total debt/total capital0.0981
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.